JMIR Res Protoc

期刊全称JMIR Res Protoc
注：上述信息均来源于网络，仅供查考，如有遗漏或信息错误，欢迎 向我反馈。

期刊相关文献 (3)

Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in Patients With Breast Cancer: Protocol for a Real-World Pragmatic Clinical Trial

中药辅助治疗在乳腺癌化疗期间预防中性粒细胞减少症和调节免疫功能的有效性：一项真实世界实用性临床试验方案

期刊:JMIR Res Protoc
影响因子:1.400
doi:10.2196/55662
Kai-Hung Wang # ，Hsuan-Shu Shen # ，Sung-Chao Chu ，Tso-Fu Wang ，Ching-Wei Lin ，Wei-Han Huang ，Yi-Feng Wu ，Ching-Chun Ho ，Cheng-Yoong Pang ，Chi-Cheng Li
发表日期：2024
全文求助 收藏

Genomic, Proteomic, and Phenotypic Biomarkers of COVID-19 Severity: Protocol for a Retrospective Observational Study

COVID-19 严重程度的基因组、蛋白质组和表型生物标志物：一项回顾性观察研究方案

期刊:JMIR Res Protoc
影响因子:1.400
doi:10.2196/50733
Andrew English ,Darren McDaid ,Seodhna M Lynch ,Joseph McLaughlin ,Eamonn Cooper ,Benjamin Wingfield ,Martin Kelly ,Manav Bhavsar ,Victoria McGilligan ,Rachelle E Irwin ,Magda Bucholc ,Shu-Dong Zhang ,Priyank Shukla ,Taranjit Singh Rai ,Anthony J Bjourson ,Elaine Murray ,David S Gibson ,Colum Walsh
发表日期：2024
全文求助 收藏

An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study

肌萎缩侧索硬化症 (ALS) 中 EPI-589 的探索性试验 (EPIC-ALS)：一项多中心、开放标签、为期 24 周的单组研究方案

期刊:JMIR Res Protoc
影响因子:1.400
doi:10.2196/42032.
Shotaro Haji,Koji Fujita,Ryosuke Oki,Yusuke Osaki,Ryosuke Miyamoto,Hiroyuki Morino,Seiichi Nagano,Naoki Atsuta,Yuki Kanazawa,Yuki Matsumoto,Atsuko Arisawa,Hisashi Kawai,Yasutaka Sato,Satoshi Sakaguchi,Kenta Yagi,Tatsuto Hamatani,Tatsuo Kagimura,Hiroaki Yanagawa,Hideki Mochizuki,Manabu Doyu,Gen Sobue,Masafumi Harada,Yuishin Izumi
ALS
发表日期：2023
全文求助 收藏
  • 1